Clinical Trials Browser

Interventional × Prostatic Diseases × enzalutamide × Clear all

NCT06496581 2024-12-20

Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)

Phase 3 Recruiting

Genital Diseases, Male, Prostatic Diseases

NCT06582628 2024-12-02

TEAM PC

Phase 2 Recruiting

Prostatic Diseases, Prostatic Neoplasms